Camber Launches Generic Ofirmev®

Piscataway, NJ, July 25, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Acetaminophen Injection to its product line.
Acetaminophen Injection is indicated for:
- Management of mild to moderate pain in adult and pediatric patients 2 years and older
- Management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older
- Reduction of fever in adult and pediatric patients
Acetaminophen Injection is available in 1000mg/100ml (10mg/ml) strength in either 10 or 24 packs of 100 mL single dose vials.
To learn more about Acetaminophen Injection, please visit https://www.camberpharma.com/acetaminophen
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025